ARMANDO CABRERA: Open Payments
NPI 1952511495 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$428 in 17 payments from 6 companies in 2025. Trend: 2023 $52 · 2024 $70 · 2025 $428
Food & beverage: $428
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $202 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $60 |
| Baxter Healthcare | 2 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $48 |
| Fisher & Paykel Healthcare Inc | 1 | $47 |
| GlaxoSmithKline, LLC. | 1 | $20 |
Products named: TEZSPIRE, FASENRA, GLASSIA, Hillrom - Vest System Model 105 Home Care, JASCAYD, FISHER & PAYKEL HEALTHCARE, BREZTRI, TRELEGY ELLIPTA.
Industry payments across FL — which companies pay providers there.
